StockNews.com Begins Coverage on Atara Biotherapeutics (NASDAQ:ATRA)
StockNews.com started coverage on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research note published on Friday. The firm issued a hold rating on the biotechnology company’s stock. Several other brokerages also recently issued reports on ATRA. Evercore ISI downgraded shares of Atara Biotherapeutics from an outperform rating to an in-line rating in […]
More Stories
Nippon Steel Finalizes $15 Billion Takeover of US Steel
By Andrew Moran Nippon Steel and U.S. Steel announced on June 18 that they have finalized their nearly $15 billion...
Federal Reserve Keeps Interest Rates Unchanged, Signals 2 Cuts This year
By Andrew Moran The Federal Reserve kept interest rates unchanged for the fourth straight meeting on June 18, a decision...
Elon Musk’s X Sues New York Over Content-Moderation Law
By Bill Pan Elon Musk’s social media platform X is suing New York state over a new law that would...
Zero Illegal Immigrants Released Into US in May: CBP
By Naveen Athrappully Border Patrol released no illegal immigrants into the country in May, a “staggering drop” from the more...
Panthers Repeat as Stanley Cup Champions, Beat Oilers in 6 Games
By The Associated Press SUNRISE, Fla.—Stanley’s stay in South Florida is getting extended. The Florida Panthers repeated as Stanley Cup...
Karen Read’s 2nd Trial Ends With Not Guilty Verdict on Murder Charge
By Bill Pan A Massachusetts jury on Wednesday found Karen Read not guilty in the death of her boyfriend, Boston...